Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06553885
What this trial is testing

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Who this might be right for
Metastatic Colorectal CancerHepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT02973672
What this trial is testing

Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas

Who this might be right for
Colon CancerRectum CancerPancreas Cancer+2 more
Surgimab 75
Early research (Phase 1)Study completedNCT01607905
What this trial is testing

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Who this might be right for
Solid Tumor
Karyopharm Therapeutics Inc 192
Large-scale testing (Phase 3)Active Not RecruitingNCT06109272
What this trial is testing

Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 89
Testing effectiveness (Phase 2)Study completedNCT00077545
What this trial is testing

3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00362102
What this trial is testing

A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
Eli Lilly and Company 38
Testing effectiveness (Phase 2)Looking for participantsNCT06529718
What this trial is testing

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Who this might be right for
Biliary Tract Cancer
UNICANCER 72
Testing effectiveness (Phase 2)Looking for participantsNCT06742892
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 90
Testing effectiveness (Phase 2)Study completedNCT00016250
What this trial is testing

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01252628
What this trial is testing

Phase 1 and 2 Study of PX-866 and Cetuximab

Who this might be right for
Incurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cascadian Therapeutics Inc. 178
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06584071
What this trial is testing

Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC

Who this might be right for
HCCLiver Cancer
Biotheus Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00114244
What this trial is testing

Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
National Cancer Institute (NCI) 52
Large-scale testing (Phase 3)Active Not RecruitingNCT06115499
What this trial is testing

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic AdenocarcinomaPancreatic Adenosquamous Carcinoma+4 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Testing effectiveness (Phase 2)Study completedNCT01877187
What this trial is testing

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Yale University 39
Not applicableEnrolling By InvitationNCT06997458
What this trial is testing

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental 500
Testing effectiveness (Phase 2)Study completedNCT00542048
What this trial is testing

A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Who this might be right for
Liver CancerNeoplasm Metastasis
MediGene 20
Large-scale testing (Phase 3)Study completedNCT05665348
What this trial is testing

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaMetastatic CancerMetastatic Tumor
Federation Francophone de Cancerologie Digestive 229
Next Page